From foundations to practice
A two-part, 144.5 hour training for clinicians and professionals preparing to work in psilocybin-assisted care, grounded in advocacy, patient-centred care, and community.
What this training prepares you for
You will learn the full TheraPsil clinical protocol, understand the Canadian legal context, and build the skills to guide patients through preparation, dosing, and integration.
- The legal and ethical landscape for psilocybin-assisted psychotherapy in Canada.
- Intake, assessment, and inclusion criteria to identify patients who may benefit.
- Psychedelic neuropharmacology, medication interactions, and risk mitigation.
- How to facilitate preparation, dosing, and integration with safety and trauma awareness.
- Supporting patients at end of life, including those with life-limiting diagnoses.
Practitioners preparing for psilocybin-assisted psychotherapy across mental health, medical, and supportive care contexts, including:
- Psychologists, counsellors, psychotherapists, and social workers
- Physicians, nurses, and nurse practitioners
- Naturopathic doctors and paramedics
- Death doulas and recognized pastoral or spiritual counsellors
Choose the format that fits
Cohorts run online and in person throughout the year for practitioners worldwide.
The full didactic program delivered live online in a weekend-intensive format, with the same curriculum and small cohort structure.
The full didactic program plus a full-day, in-person breathwork experience as part of the training week.
Recognized, accredited training
144.5 hours of training approved by the CPA and CCPA, with 30 hours approved by the OPQ.
TheraPsil is approved by the Canadian Psychological Association to offer continuing education for psychologists, and maintains responsibility for the program.
See how the program feels
Yasmeen, TheraPsil's Director of Training and Operations, walks through the training from application to completion, showing how each step fits together.
Breathwork and grounding are woven into the in-person intensive. Trainees learn to guide these practices, and to use them for their own regulation and resilience.
TheraPsil's founder, Dr. Bruce Tobin, outlines the clinical research that informs the program and the protocol trainees learn to apply with patients.
Experience the medicine yourself
Through PsilWell, our clinical trial with Hippo Science, you can add a supervised, Health Canada-authorized psilocybin session to your training.
